相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of liver-derived bone morphogenetic protein (BMP)-9 as a potential new candidate for treatment of colorectal cancer
Chen Cai et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)
BMP9 promotes methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in non-obese mice by enhancing NF-κB dependent macrophage polarization
Qianqian Jiang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLD
Guido Carpino et al.
HEPATOLOGY (2020)
BMP-9 Modulates the Hepatic Responses to LPS
Haristi Gaitantzi et al.
CELLS (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
New insights into BMP9 signaling in organ fibrosis
Nan Tang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
CRISPR-mediated BMP9 ablation promotes liver steatosis via the down-regulation of PPARα expression
Z. Yang et al.
SCIENCE ADVANCES (2020)
FGF19 subfamily members: FGF19 and FGF21
Katarzyna Dolegowska et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2019)
Interactive association of lipopolysaccharide and free fatty acid with the prevalence of type 2 diabetes: A community-based cross-sectional study
Xiuji Huang et al.
JOURNAL OF DIABETES INVESTIGATION (2019)
Role of bone morphogenetic protein-9 in the regulation of glucose and lipid metabolism
Min Yang et al.
FASEB JOURNAL (2019)
Differential Consequences of Bmp9 Deletion on Sinusoidal Endothelial Cell Differentiation and Liver Fibrosis in 129/Ola and C57BL/6 Mice
Agnes Desroches-Castan et al.
CELLS (2019)
Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis
Mary E. Rinella et al.
JOURNAL OF HEPATOLOGY (2019)
BMP Signalling at the Crossroad of Liver Fibrosis and Regeneration
Blanca Herrera et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
An Overview of FGF19 and FGF21: The Therapeutic Role in the Treatment of the Metabolic Disorders and Obesity
Nasim Babaknejad et al.
HORMONE AND METABOLIC RESEARCH (2018)
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A. Harrison et al.
LANCET (2018)
BMP-9 interferes with liver regeneration and promotes liver fibrosis
Katja Breitkopf-Heinlein et al.
GUT (2017)
Circulating bone morphogenetic protein-9 in relation to metabolic syndrome and insulin resistance
Xiaohui Xu et al.
SCIENTIFIC REPORTS (2017)
Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies
John Vizuete et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2017)
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
Chiara Degirolamo et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
BMP-9 enhances fibroblast growth factor 21 expression and suppresses obesity
Sooho Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Endoglin targeting inhibits tumor angiogenesis and metastatic spread in breast cancer
M. Paauwe et al.
ONCOGENE (2016)
Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet
Naoki Tanaka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases
Fangfang Zhang et al.
MOLECULAR ENDOCRINOLOGY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Long-lasting anti-diabetic efficacy of PEGylated FGF-21 and liraglutide in treatment of type 2 diabetic mice
Xianlong Ye et al.
ENDOCRINE (2015)
BMP-9 as a potent brown adipogenic inducer with anti-obesity capacity
Mario Meng-Chiang Kuo et al.
BIOMATERIALS (2014)
Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes
B. Jayashree et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Fibroblast Growth Factor-19 Action in the Brain Reduces Food Intake and Body Weight and Improves Glucose Tolerance in Male Rats
Karen K. Ryan et al.
ENDOCRINOLOGY (2013)
Proteome-wide analyses of human hepatocytes during differentiation and dedifferentiation
Cliff Rowe et al.
HEPATOLOGY (2013)
Circulating bone morphogenetic protein levels and delayed fracture healing
Laurens J. van Baardewijk et al.
INTERNATIONAL ORTHOPAEDICS (2013)
BMP9 and BMP10 are critical for postnatal retinal vascular remodeling
Nicolas Ricard et al.
BLOOD (2012)
E-cadherin is required for intestinal morphogenesis in the mouse
Benjamin J. Bondow et al.
DEVELOPMENTAL BIOLOGY (2012)
Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex
Sharon A. Townson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
Chaofeng Yang et al.
PLOS ONE (2012)
FGF15/19 Regulates Hepatic Glucose Metabolism by Inhibiting the CREB-PGC-1α Pathway
Matthew J. Potthoff et al.
CELL METABOLISM (2011)
A framework for oligonucleotide microarray preprocessing
Benilton S. Carvalho et al.
BIOINFORMATICS (2010)
Symposium 1: Overnutrition: consequences and solutions Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome
J. Bernadette Moore
PROCEEDINGS OF THE NUTRITION SOCIETY (2010)
Bile Acids Activate Fibroblast Growth Factor 19 Signaling in Human Hepatocytes to Inhibit Cholesterol 7 alpha-Hydroxylase Gene Expression
Kwang-Hoon Song et al.
HEPATOLOGY (2009)
Extracellular Matrix Modulates Sensitivity of Hepatocytes to Fibroblastoid Dedifferentiation and Transforming Growth Factor β-induced Apoptosis
Patricio Godoy et al.
HEPATOLOGY (2009)
FGF21 induces PGC-1α and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response
Matthew J. Potthoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice
Patrice D. Cani et al.
DIABETES (2008)
FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet-induced fatty liver
Xinqiang Huang et al.
DIABETES (2007)
Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor Isoforms determines metabolic activity of FGF19 and FGF21
Hiroshi Kurosu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
INDUCTION OF DIABETES BY STREPTOZOTOCIN IN RATS
A. Akbarzadeh et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2007)
βKlotho is required for metabolic activity of fibroblast growth factor 21
Yasushi Ogawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members
Regina Goetz et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6
Jaroslav Truksa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
T Inagaki et al.
CELL METABOLISM (2005)
An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis
C Chen et al.
NATURE BIOTECHNOLOGY (2003)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Bone morphogenetic protein-9 - An autocrine/paracrine cytokine in the liver
AF Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
